Skip to main content

MPH Health Care AG Value Stock - Dividend - Research Selection

MPH Health Care AG

ISIN: DE000A0L1H32, WKN: A0L1H3

Market price date: 21.05.2021
Market price: 25,80 EUR




MPH Health Care AG Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 30-05-2020
Cash flow
Net operating cash flow -1.351.420
Capital Expenditures -52.466
Free cash flow -1.403.886
Balance sheet
Total Equity 271.641.000
Liabilities & Shareholders equity 293.144.000
Income statement
Net income 11.076.000
Eps (diluted) 2,600
Diluted shares outstanding 4.260.000
Net sales/revenue 41.200.000

Fundamental ratios calculated on: 21-05-2021

Ratios
Key figures 21-05-2021
Cash flow
P/C -81,33
   
P/FC -78,29
Balance sheet
ROI3,78
ROE92,67
Income statement
P/E9,92
Div. Yield0,00%
P/B0,41
P/S2,67


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol93M1.XETRA
Market Capitalization133.302.608,00 USD
Country
IndicesNO INDEX
Sectors
Raw Data SourceIFRS in Millionen EUR
Stock Split2020-09-22,1.000000/10.000000; 2014-09-04,26.000000/25.000000
Internetwww.mph-ag.de


Description of the company

MPH Mittelstaendische Pharma Holding AG is a German-based company engaged, through its subsidiaries, in the development, production, licensing, and sale of generics in Germany. The Company also involves in the licensing and import of patent protected EU branded pharmaceuticals. Its product line includes pharmaceutical products for oncology, HIV, neurology, rheumatism, cardiovascular, lifestyle medicine, and rheumatology. The Company also provides veterinary pharmaceutical and medical products, as well as animal complement feed. Its veterinary products primarily focus on horse therapy treatment, which comprise products for the musculoskeletal system and immune system.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.mph-ag.de